# Esmolol Versus Lidocaine on the Quality of Postoperative Recovery in Patients Undergoing Functional Endoscopic Sinus Surgery

> **NCT06457100** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **The Second People's Hospital of Huai'an** · enrollment: 60 (estimated)

## Conditions studied

- Chronic Rhinosinusitis
- Enhanced Recovery After Surgery

## Interventions

- **DRUG:** Esmolol Injection
- **DRUG:** Lidocaine IV

## Key facts

- **NCT ID:** NCT06457100
- **Lead sponsor:** The Second People's Hospital of Huai'an
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-11-21
- **Primary completion:** 2024-06-15
- **Final completion:** 2024-06-22
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06457100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06457100, "Esmolol Versus Lidocaine on the Quality of Postoperative Recovery in Patients Undergoing Functional Endoscopic Sinus Surgery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06457100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*